Contineum Therapeutics (CTNM) Tax Rate (2023)

Contineum Therapeutics' (CTNM) quarterly Tax Rate came in at 7.5% in Q4 2023, up 377.88% quarter-over-quarter from 1.57% in Q3 2023.

Contineum Therapeutics (CTNM) Tax Rate (2023) Analysis & Trends

Contineum Therapeutics' Tax Rate history runs 1 years deep, the most recent figure standing at 7.5% for Q4 2023.

On a quarterly basis, Tax Rate changed N/A year-over-year to 7.5% in Q4 2023; TTM through Sep 2024 was 1.67%, a N/A change from a year earlier, with the FY2023 full-year figure at 0.02%, changed N/A from the prior year.
Tax Rate grew to 7.5% in Q4 2023 per CTNM's latest filing, from 1.57% in the prior quarter.
Across five years, Tax Rate topped out at 7.5% in Q4 2023 and bottomed at 1.57% in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-0.34
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	5.61
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	12.29
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	17.68
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	12.51
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-13.70
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Contineum Therapeutics	524.99 Mn	524.99 Mn	-	-

Download Data